RxDoctor Payments Data

Jennifer Roby

Family · Plain City, OHNPI 1427507995

Payments from drug & device makers

$1,587in general payments, 2019–2025

Across 129 payments — averaging $12.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$907
  • Abbott$134
  • Xeris Pharmaceuticals, Inc.$69
  • AstraZeneca$60
  • Novo Nordisk$58
  • Amarin Pharma, Inc.$55
  • plus $303 from 12 others

What the payments were for

  • Food & beverage$1,587100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,587 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$8,230
Medicare patients
34
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban26$39,712
Albuterol Sulfate HfaAlbuterol Sulfate23$583
Atorvastatin Calcium78$571
Levothyroxine Sodium54$480
Potassium Chloride19$462
Omeprazole28$397
Metoprolol Succinate27$317
Pantoprazole Sodium12$305
Lisinopril60$268
Tizanidine Hcl28$250
Sertraline Hcl40$219
Fluticasone Propionate29$174
Pioglitazone Hcl17$171
Losartan Potassium17$159
Carvedilol35$159

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$44$39,71226 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Plain City

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →